phenobarbital has been researched along with Immunoblastic Lymphadenopathy in 1 studies
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
Immunoblastic Lymphadenopathy: A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rubiés-Prat, J | 1 |
| Vidal, MT | 1 |
| Clotet, B | 1 |
| Moragas, A | 1 |
1 other study available for phenobarbital and Immunoblastic Lymphadenopathy
| Article | Year |
|---|---|
[Angioimmunoblastic lymphadenopathy. Immunocytochemical, morphological and mathematical study of lymph node biopsy (author's transl)].
Topics: Aged; Biopsy; Drug Combinations; Female; Histocytochemistry; Humans; Immunoblastic Lymphadenopathy; | 1981 |